Hartford Financial Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.1K | Sell |
374
-38
| -9% | -$5.32K | 0.01% | 189 |
|
|
2025
Q4 | $50.6K | Hold |
412
| – | – | 0.01% | 189 |
|
|
2025
Q3 | $45.7K | Hold |
412
| – | – | 0.01% | 191 |
|
|
2025
Q2 | $45.7K | Sell |
412
-61
| -13% | -$6.49K | 0.01% | 192 |
|
|
2025
Q1 | $53K | Hold |
473
| – | – | 0.01% | 204 |
|
|
2024
Q4 | $43.7K | Sell |
473
-40
| -8% | -$3.6K | 0.01% | 217 |
|
|
2024
Q3 | $43K | Sell |
513
-17
| -3% | -$1.3K | 0.01% | 227 |
|
|
2024
Q2 | $36.4K | Buy |
530
+21
| +4% | +$1.4K | 0.01% | 237 |
|
|
2024
Q1 | $37.3K | Buy |
509
+113
| +29% | +$8.69K | 0.01% | 246 |
|
|
2023
Q4 | $32.1K | Buy |
396
+121
| +44% | +$9.42K | 0.01% | 251 |
|
|
2023
Q3 | $20.6K | Buy |
+275
| New | +$21.2K | 0.01% | 259 |
|
|
2022
Q3 | – | Sell |
-70
| Closed | -$4K | – | 384 |
|
|
2022
Q2 | $4K | Hold |
70
| – | – | ﹤0.01% | 329 |
|
|
2022
Q1 | $4K | Hold |
70
| – | – | ﹤0.01% | 338 |
|
|
2021
Q4 | $5K | Sell |
70
-135
| -66% | -$9.3K | ﹤0.01% | 320 |
|
|
2021
Q3 | $14K | Buy |
205
+135
| +193% | +$9.48K | ﹤0.01% | 269 |
|
|
2021
Q2 | $5K | Hold |
70
| – | – | ﹤0.01% | 331 |
|
|
2021
Q1 | $5K | Hold |
70
| – | – | ﹤0.01% | 336 |
|
|
2020
Q4 | $4K | Buy |
+70
| New | +$4.22K | ﹤0.01% | 317 |
|
|
2020
Q2 | – | Sell |
-140
| Closed | -$10K | – | 347 |
|
|
2020
Q1 | $10K | Hold |
140
| – | – | ﹤0.01% | 262 |
|
|
2019
Q4 | $9K | Hold |
140
| – | – | ﹤0.01% | 297 |
|
|
2019
Q3 | $9K | Hold |
140
| – | – | ﹤0.01% | 298 |
|
|
2019
Q2 | $9K | Hold |
140
| – | – | ﹤0.01% | 298 |
|
|
2019
Q1 | $9K | Hold |
140
| – | – | ﹤0.01% | 306 |
|
|
2018
Q4 | $9K | Hold |
140
| – | – | ﹤0.01% | 312 |
|
|
2018
Q3 | $11K | Hold |
140
| – | – | ﹤0.01% | 314 |
|
|
2018
Q2 | $10K | Hold |
140
| – | – | ﹤0.01% | 328 |
|
|
2018
Q1 | $10K | Hold |
140
| – | – | 0.01% | 263 |
|
|
2017
Q4 | $10K | Hold |
140
| – | – | ﹤0.01% | 270 |
|
|
2017
Q3 | $11K | Hold |
140
| – | – | 0.01% | 292 |
|
|
2017
Q2 | $9K | Hold |
140
| – | – | ﹤0.01% | 291 |
|
|
2017
Q1 | $9K | Hold |
140
| – | – | 0.01% | 270 |
|
|
2016
Q4 | $10K | Hold |
140
| – | – | 0.01% | 238 |
|
|
2016
Q3 | $11K | Hold |
140
| – | – | 0.01% | 233 |
|
|
2016
Q2 | $11K | Hold |
140
| – | – | 0.01% | 209 |
|
|
2016
Q1 | $12K | Hold |
140
| – | – | 0.01% | 200 |
|
|
2015
Q4 | $14K | Hold |
140
| – | – | 0.01% | 198 |
|
|
2015
Q3 | $13K | Hold |
140
| – | – | 0.01% | 192 |
|
|
2015
Q2 | $16K | Buy |
+140
| New | +$15.3K | 0.01% | 200 |
|
|
2015
Q1 | – | Sell |
-140
| Closed | -$13K | – | 151 |
|
|
2014
Q4 | $13K | Hold |
140
| – | – | 0.01% | 184 |
|
|
2014
Q3 | $14K | Hold |
140
| – | – | 0.01% | 199 |
|
|
2014
Q2 | $11K | Buy |
+140
| New | +$10.9K | 0.01% | 205 |
|
Other funds holding GILD
VCM
VPM
Hartford Financial Management's GILD Position: Q1 2026 in Review
Hartford Financial Management reduced its Gilead Sciences (GILD) stake by 9.2% in Q1 2026, selling an estimated $5.32K and leaving 374 shares worth $52.1K. The position accounts for 0.01% of the portfolio, ranked #189.
Hartford Financial Management first reported a position in GILD in Q2 2014 and has held it in 41 quarters since. The position peaked at $53K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Hartford Financial Management held 374 shares of Gilead Sciences worth $52.1K as of Q1 2026.
- Hartford Financial Management sold 38 Gilead Sciences shares in Q1 2026, an estimated $5.32K.
- Gilead Sciences made up 0.01% of Hartford Financial Management's portfolio in Q1 2026, its #189 holding.
- Hartford Financial Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 41 quarters since.
- Hartford Financial Management's Gilead Sciences position peaked at $53K in Q1 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Hartford Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.